R Scott McIvor
Affiliations: | Microbiology, Immunology and Cancer Biology | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Molecular Biology, Virology Biology, Microbiology BiologyGoogle:
"R McIvor"Children
Sign in to add trainee| Seth D. Hartung | grad student | 2003 | UMN |
| Colin L. Sweeney | grad student | 2003 | UMN |
| Andrew C. Wilber | grad student | 2006 | UMN |
| Paul R. Score | grad student | 2008 | UMN |
| Megan M. Multhaup | grad student | 2010 | UMN |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Webber BR, Johnson MJ, Skeate JG, et al. (2023) Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair. Nature Biomedical Engineering |
| Cowan MJ, Yu J, Facchino J, et al. (2022) Lentiviral Gene Therapy for Artemis-Deficient SCID. The New England Journal of Medicine. 387: 2344-2355 |
| Sipe CJ, Kluesner MG, Bingea SP, et al. (2022) Correction of Fanconi Anemia Mutations Using Digital Genome Engineering. International Journal of Molecular Sciences. 23 |
| Belur LR, Podetz-Pedersen KM, Tran TA, et al. (2020) Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10. Molecular Genetics and Metabolism Reports. 24: 100604 |
| McIvor RS, de Laat R, Mei X, et al. (2020) Iduronidase-transposed human B lymphocytes correct enzyme deficiency and glycosaminoglycan storage disease in immunodeficient mucopolysaccharidosis type I mice Molecular Genetics and Metabolism. 129: S108 |
| Belur L, McKenzie J, Podetz-Pedersen K, et al. (2020) Systemic high-level IDUA enzyme activity with correction of neurologic deficit in mucopolysaccharidosis type I mice by lentiviral transduction of hematopoietic stem cells Molecular Genetics and Metabolism. 129: S30-S31 |
| Cowan MJ, Yu J, Facchino J, et al. (2020) Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) Biology of Blood and Marrow Transplantation. 26: S88-S89 |
| Ou L, DeKelver RC, Rohde M, et al. (2018) ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Laoharawee K, DeKelver RC, Podetz-Pedersen KM, et al. (2018) Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Aronovich EL, Hyland KA, Hall BC, et al. (2017) Prolonged expression of secreted enzymes in dogs after liver-directed delivery of Sleeping Beauty transposons: implications for non-viral gene therapy of systemic disease. Human Gene Therapy |